Stocktoria
CG Oncology, Inc. CGON
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2024-01-25
CG Oncology, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 1,976,070 | $62.4M | 2.45% |
| CITADEL ADVISORS LLC | 159,100 | $11.3M | 0.2% |
| AQR CAPITAL MANAGEMENT LLC | 102,397 | $7.3M | 0.13% |
| D. E. Shaw & Co., Inc. | 89,417 | $6.4M | 0.11% |
| MILLENNIUM MANAGEMENT LLC | 20,000 | $1.4M | 0.02% |
| Point72 Asset Management, L.P. | 9,200 | $653,660 | 0.01% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.